Breast cancer resistance protein polymorphism ABCG2 c.421C>A (rs2231142) moderates the effect of valproate on lamotrigine trough concentrations in adults with epilepsy
Fundamental & Clinical Pharmacology · 2024-04 · 38 (2) · 351-368
DOI: 10.1111/fcp.12958 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fundamental & Clinical Pharmacology, online erschienen am 04.10.2023. Verfasst von Ivana Šušak Sporiš und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Hospital Dubrava, Zagreb, Croatia. Hauptthemen laut MEDLINE: Epilepsy, Breast Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
Background
Valproate inhibits clearance of lamotrigine and greatly increases its concentrations. We assessed whether this effect was moderated by a polymorphism ( ABCG2 c.421C>A ) of the breast cancer resistance protein.
Methods
In two consecutive independent studies in adults with epilepsy on lamotrigine monotherapy or cotreated with valproate: (i) Exposure to valproate was considered treatment, (ii) dose‐adjusted lamotrigine troughs at steady state were the outcome, and (iii) ABCG2 c.421C>A genotype (wild‐type [wt] homozygosity or variant carriage) was the tested moderator. We used entropy balancing (primary analysis) and exact/optimal full matching (secondary analysis) to control for confounding, including polymorphisms (and linked polymorphisms) suggested to affect exposure to lamotrigine ( UGT1A4*3 c.142T>G , rs2011425; UGT2B7–161C>T , rs7668258; ABCB1 1236C>T , rs1128503) to generate frequentist and Bayesian estimates of valproate effects (geometric means ratios [GMR]).
Results
The two studies yielded consistent results (replicated); hence, we analyzed combined data (total N = 471, 140 treated, 331 controls, 378 ABCG2 c.421C>A wt subjects, 93 variant carriers). Primary analysis: in variant carriers, valproate effect (GMR) on lamotrigine (treated, n = 21 vs. controls, n = 72) was around 60% higher than in wt subjects (treated, n = 119 vs. controls, n = 259)—ratio of GMRs 1.61 (95%CI 1.23–2.11) (frequentist) and 1.63 (95%CrI 1.26–2.10) (Bayes). Similar differences in valproate effects between variant carriers and wt subjects were found in the secondary analysis (valproate troughs up to 364 μmol/L vs. no valproate; or valproate ≥364 μmol/L vs. no valproate). Susceptibility of the estimates to unmeasured confounding was low.
Conclusion
Data suggest that polymorphism rs2231142 moderates the effect of valproate on exposure to lamotrigine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, University Hospital Dubrava, Zagreb, Croatia.
- Faculty of Dental Medicine and Health, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia.
- Department of Pharmacology, Zagreb University School of Medicine, Zagreb, Croatia.
- Croatian Agency for Medicinal Products and Medical Devices, Zagreb, Croatia.
- Analytical Toxicology and Pharmacology Division, Department of Laboratory Diagnostics, University Hospital Centre Zagreb, Zagreb, Croatia.
- Division of Pharmacogenomics and Therapy Individualization, Department of Laboratory Diagnostics, University Hospital Centre Zagreb, Zagreb, Croatia.
ORCID-Profile: Vladimir Trkulja
Zitieren
APA
Šušak Sporiš, I., Božina, N., Klarica Domjanović, I., Sporiš, D., Bašić, S., Bašić, I., Lovrić, M., Ganoci, L., & Trkulja, V. (2024). Breast cancer resistance protein polymorphism ABCG2 c.421C>A (rs2231142) moderates the effect of valproate on lamotrigine trough concentrations in adults with epilepsy. Fundamental & Clinical Pharmacology, 38(2), 351-368. https://doi.org/10.1111/fcp.12958
Vancouver
Šušak Sporiš I, Božina N, Klarica Domjanović I, Sporiš D, Bašić S, Bašić I, et al. Breast cancer resistance protein polymorphism ABCG2 c.421C>A (rs2231142) moderates the effect of valproate on lamotrigine trough concentrations in adults with epilepsy. Fundamental & Clinical Pharmacology. 2024;38(2):351-368. doi:10.1111/fcp.12958
BibTeX
@article{uakSpori2024,
author = {Šušak Sporiš, Ivana and Božina, Nada and Klarica Domjanović, Iva and Sporiš, Davor and Bašić, Silvio and Bašić, Ivana and Lovrić, Mila and Ganoci, Lana and Trkulja, Vladimir},
title = {Breast cancer resistance protein polymorphism ABCG2 c.421C>A (rs2231142) moderates the effect of valproate on lamotrigine trough concentrations in adults with epilepsy},
journal = {Fundamental & Clinical Pharmacology},
year = {2024},
volume = {38},
number = {2},
pages = {351--368},
doi = {10.1111/fcp.12958}
}
EUVIMED